MediWound Ltd.

Good day and welcome to Meadow Wounds second quarter 2022 earnings call. Today's conference is being recorded. At this time, I would like to turn the conference over to Monique Cossie of LifeSite Advisors.

Please go ahead. Thank you, operator, and welcome everyone.

Earlier today, Meadowoon issued a press release announcing financial results for the second quarter ended June 30, 2022. You may access that release on the company's website under the Investors tab. With us today are Ofer Gonen, Chief Executive Officer of Meadowoon, and Boaz Gurlevi, Chief Financial Officer. Following our prepared remarks, we will open the call for Q&A. Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session relating to Meadowern's expected future performance, future business prospects, or future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. Although the company believes that expectations reflected in such forward-looking statements are based upon reasonable assumptions, Actual outcomes and results are subject to risks and uncertainties and could differ materially from those forecast due to the impact of many factors beyond the control of MetaWolf. The company assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events, or otherwise. Participants are directed to cautionary notes set forth in today's press release, as well as the risk factors set forth in Metawound's annual report filed with the SEC for factors that could cause actual results to differ materially from those anticipated in the forward-looking statements. The conference call is the property of Metawound, and any recording or rebroadcast is expressly prohibited without the written consent of Metawound. Now I would like to turn the call over to Ofer Gonan, Chief Executive Officer of MediWound.